Understanding the Scientific Issues Embedded in the Generic Drug Approval Process
- 1 November 2001
- journal article
- review article
- Published by Elsevier BV in Journal of the American Pharmaceutical Association
- Vol. 41 (6), 856-867
- https://doi.org/10.1016/s1086-5802(16)31327-4
Abstract
No abstract availableKeywords
Funding Information
- Blue Cross Blue Shield of Michigan Foundation
This publication has 31 references indexed in Scilit:
- Transplant pharmacists’ opinions on generic product selection of critical-dose drugsAmerican Journal of Health-System Pharmacy, 1999
- A Physician Survey on Generic Drugs and Substitution of Critical Dose MedicationsArchives of Internal Medicine, 1997
- Generic DrugsDrug Safety, 1996
- Bioequivalence and Generic Prescribing: An Industrial ViewJournal of Pharmacy and Pharmacology, 1996
- Bioequivalence requirements for generic productsPharmacology & Therapeutics, 1994
- Bioinequivalence and Drug ToxicityDrug Safety, 1994
- Controversies in Bioequivalence StudiesClinical Pharmacokinetics, 1992
- Drug Product Selection-Part 2: Scientific Basis of Bioavailability and Bioequivalence TestingAmerican Pharmacy, 1991
- Generic Equivalents: Issues and ConcernsThe Journal of Clinical Pharmacology, 1986
- Bioavailability and BioequivalenceThe Journal of Clinical Pharmacology, 1976